GMA301 was selected as “National Mega-Innovative Program”

April 6, 2017, GMA301 was selected as the “National Mega-Innovative Program” for the 13th Five Year Plan.

CFDA Proposes to Reform the Process of Imported Drug Approval

Transferred from CFDA

CFDA Issues Regulatory Reformation Proposal Draft on Drug Life Cycle M

CFDA proposes a regulation reformation draft on life cycle management: shorten the timeline for IND approval, loosen control over clinical trial sites and improve IP protection for…

The ICH Assembly approved the China Food and Drug Administration as a

The International Council for Harmonization (ICH) met in Montreal, Canada from May 31 to June 1, 2017. The ICH Assembly approved the CFDA as a new Regulatory Member.

China's Ministry of Human Resources adds 36 drugs to NDRL after Price

China will add 36 new drugs to the health insurance list: category B, after price negotiation with the manufacturers.